The Human Cancer PrimaCell™ 10: Liver Tumor Cells is for rapid (7-10 days) isolation and growth of human Liver tumor cells from human liver tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 6-8 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 10 System (Cat No. 2-96033):
Human Cancer PrimaCell™ 10: Liver Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 10: Liver Tumor Cells
Human Cancer OptiTDS™ 10: Tissue Dissociation System
Human Cancer PrimaCell™ 10: Liver Tumor Cells Growth Medium
Human Cancer PrimaCell™ 10: Liver Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Yamaguchi T, Ichise T, Iwata O, Hori A, Adachi T, Nakamura M, Yoshida N, Ichise H. Development of a new method for isolation and long-term culture of organ-specific blood vascular and lymphatic endothelial cells of the mouse. FEBS J. 2008 May;275(9):1988-98. Epub 2008 Mar 17.
[2] Ceafalan L, Vidulescu C, Radu E, Regalia T, Popescu I, Pana M, Serghei L, Voiculescu B, Popescu LM. Expression of stem cell markers on fetal and tumoral human liver cells in primary culture. Rev Med Chir Soc Med Nat Iasi. 2005 Jan-Mar;109(1):96-104. Romanian.
[3] Vona G, Estepa L, Béroud C, Damotte D, Capron F, Nalpas B, Mineur A, Franco D, Lacour B, Pol S, Bréchot C, Paterlini-Bréchot P. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology. 2004 Mar;39(3):792-7.